MEDINFAR is a leading Portuguese pharmaceutical group with a strong presence in the Consumer Health and Dermatology sectors. Established in 1970, we have become a driving force in Portugal, holding the top position in the Consumer Health and Dermatology categories and ranking as the 3rd largest pharmaceutical company in the country.

Committed to innovation, our Research and Development Laboratory focuses on creating new products, processes, and analytical methodologies, ensuring that we continually deliver cutting-edge solutions to our clients. With a global presence in over 70 countries, we export and partner with companies internationally, managing more than 800 registrations worldwide. Our state-of-the-art Industrial Unit has been pivotal since our inception, evolving into a hub of technological and industrial expertise.

We are dedicated to developing therapeutic solutions in areas such as Consumer Health, Endocrinology, Respiratory, Dermatology, and Veterinary medicine with a focus on commercial effectiveness and compliance. With a workforce of over 430 employees, we manufactured 30 million units in 2019, emphasizing our commitment to quality and innovation. With a strong emphasis on compliance, pharmacovigilance, and corporate social responsibility, MEDINFAR is proud to leave a significant mark on the future of healthcare.